glp-1 receptor agonists side effects GI Adverse of Glucagon-Like Peptide-1 Non-insulin injectable antidiabetic drugs -

European Journal of Endocrinology, 144 (1), 1-9

Peng L, Wen L, Shi QF, Gao F, Huang B, Meng J, Hu CP, Wang CM

Please see all pictures before purchasing

Cell metabolism , 21 (3), 443454

For most GLP-1 medications, the FDA labeling provides specific guidance on administration timing

resets to 5 year CMT + 2.340% to 6/15/31 and every 5 years thereafter Final Maturity: Perpetual Payment Dates: 03/15, 06/15, 09/15, 12/15 Record Dates: Last business day of month preceding payment date Dividend Equalization Preferred Shares (see more information below) (WFCNP) CUSIP: 949746887 Amount: 97,000 shares Announcement Date: 09/01/2001 Callable on or after: 01/01/2022 Coupon: Not applicable Final Maturity: Perpetual Payment Dates: Not applicable Record Dates: Not applicable Contact information Investor Relations 1-415-371-2921 [email protected] Computershare Trust Co